Literature DB >> 27033190

Phytometabolites Targeting the Warburg Effect in Cancer Cells: A Mechanistic Review.

Mohadeseh Hasanpourghadi1, Chung Yeng Looi1, Ashok Kumar Pandurangan1, Gautam Sethi2, Won Fen Wong3, Mohd Rais Mustafa1.   

Abstract

Phytometabolites are functional elements derived from plants and most of them exhibit therapeutic characteristics such as anti-cancer, anti-inflammatory and anti-oxidant effects. Phytometabolites exert their anti-cancer effect by targeting multiple signaling pathways. One of the remarkable phenomena targeted by phytometabolites is the Warburg effect. The Warburg effect describes the observation that cancer cells exhibit an increased rate of glycolysis and aberrant redox activity compared to normal cells. This phenomenon promotes further cancer development and progression. Recent observations revealed that some phytometabolites could target metabolic-related enzymes (e.g. Hexokinase, Pyruvate kinase M2, HIF-1) in cancer cells, with little or no harm to normal cells. Since hyper-proliferation of cancer cells is fueled by higher cellular metabolism, phytometabolites targeting these metabolic pathways can create synergistic crosstalk with induced apoptotic pathways and sensitize cancer cells to chemotherapeutic agents. In this review, we discuss phytometabolites that target the Warburg effect and the underlying molecular mechanism that leads to tumor growth suppression. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Cancer; glycolysis; oxidative phosphorylation; phytometabolites; redox activity; warburg effect

Mesh:

Substances:

Year:  2017        PMID: 27033190     DOI: 10.2174/1389450117666160401124842

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  10 in total

Review 1.  Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases.

Authors:  Shruti Mishra; Sumit S Verma; Vipin Rai; Nikee Awasthee; Srinivas Chava; Kam Man Hui; Alan Prem Kumar; Kishore B Challagundla; Gautam Sethi; Subash C Gupta
Journal:  Cell Mol Life Sci       Date:  2019-03-16       Impact factor: 9.261

Review 2.  The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis.

Authors:  Min Yu; Han Yongzhi; Shengying Chen; Xiaodan Luo; Ye Lin; Yu Zhou; Haosheng Jin; Baohua Hou; Yanying Deng; Lei Tu; Zhixiang Jian
Journal:  Oncotarget       Date:  2017-06-27

3.  Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis.

Authors:  Wei Li; Feng Gao; Xiaoqian Ma; Ruike Wang; Xin Dong; Wei Wang
Journal:  Oncotarget       Date:  2017-05-16

4.  CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma.

Authors:  Juan Su; Tianyuan Gao; Minghao Jiang; Lisha Wu; Weiqi Zeng; Shuang Zhao; Cong Peng; Xiang Chen
Journal:  Oncotarget       Date:  2016-10-04

Review 5.  Molecular Mechanisms of Action of Tocotrienols in Cancer: Recent Trends and Advancements.

Authors:  Vaishali Aggarwal; Dharambir Kashyap; Katrin Sak; Hardeep Singh Tuli; Aklank Jain; Ashun Chaudhary; Vivek Kumar Garg; Gautam Sethi; Mukerrem Betul Yerer
Journal:  Int J Mol Sci       Date:  2019-02-02       Impact factor: 5.923

Review 6.  An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases.

Authors:  Nand Kishor Roy; Dey Parama; Kishore Banik; Devivasha Bordoloi; Amrita Khwairakpam Devi; Krishan Kumar Thakur; Ganesan Padmavathi; Mehdi Shakibaei; Lu Fan; Gautam Sethi; Ajaikumar B Kunnumakkara
Journal:  Int J Mol Sci       Date:  2019-08-22       Impact factor: 5.923

7.  ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway.

Authors:  Dafeng Xu; Yu Wang; Jincai Wu; Zhensheng Zhang; Jiacheng Chen; Mingwei Xie; Rong Tang; Cheng Chen; Liang Chen; Shixun Lin; Xiangxiang Luo; Jinfang Zheng
Journal:  Cell Death Dis       Date:  2021-02-08       Impact factor: 8.469

Review 8.  Focus on Formononetin: Anticancer Potential and Molecular Targets.

Authors:  Samantha Kah Ling Ong; Muthu K Shanmugam; Lu Fan; Sarah E Fraser; Frank Arfuso; Kwang Seok Ahn; Gautam Sethi; Anupam Bishayee
Journal:  Cancers (Basel)       Date:  2019-05-01       Impact factor: 6.639

9.  SALL4 promotes gastric cancer progression via hexokinase II mediated glycolysis.

Authors:  Meng Shao; Jiayin Zhang; Jiahui Zhang; Hui Shi; Yu Zhang; Runbi Ji; Fei Mao; Hui Qian; Wenrong Xu; Xu Zhang
Journal:  Cancer Cell Int       Date:  2020-05-24       Impact factor: 5.722

10.  An Investigation on the Therapeutic Potential of Butein, A Tretrahydroxychalcone Against Human Oral Squamous Cell Carcinoma.

Authors:  Devivasha Bordoloi; Javadi Monisha; Nand Kishor Roy; Ganesan Padmavathi; Kishore Banik; Choudhary Harsha; Hong Wang; Alan Prem Kumar; Frank Arfuso; Ajaikumar B Kunnumakkara
Journal:  Asian Pac J Cancer Prev       Date:  2019-11-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.